2.19
1.39%
0.03
Handel nachbörslich:
2.19
Schlusskurs vom Vortag:
$2.16
Offen:
$2.14
24-Stunden-Volumen:
165.08K
Relative Volume:
1.68
Marktkapitalisierung:
$146.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-1.0529
EPS:
-2.08
Netto-Cashflow:
$-60.14M
1W Leistung:
-8.37%
1M Leistung:
-11.69%
6M Leistung:
-30.91%
1J Leistung:
+65.91%
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-02-24 | Eingeleitet | William Blair | Outperform |
2021-02-18 | Eingeleitet | Needham | Buy |
2020-07-07 | Eingeleitet | Cowen | Outperform |
2020-07-07 | Eingeleitet | JP Morgan | Overweight |
2020-07-07 | Eingeleitet | Jefferies | Buy |
2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Promising Penny Stocks On US Exchanges In November 2024 - Simply Wall St
Researchers Seek to Unlock the Secrets to Human Longevity - Securities.io
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock - Yahoo Finance
ST Launches AI-enhanced Bio-Sensing Chip for Next-gen Wearables - EE Times India
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in October - MarketBeat
Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com
Generation Bio (NASDAQ:GBIO) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT - The Bakersfield Californian
Generation Bio Announces the Presentation of Preclinical - GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - StockTitan
Cubist Systematic Strategies LLC Has $54,000 Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in September - MarketBeat
Viral And Non-Viral Vector Manufacturing Market Report 2024-2033 | Size, Trends, Outlook - WhaTech
Alnylam’s founder brings in a $135M series A for City Therapeutics - BioWorld Online
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based Medicine - Pulse 2.0
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine - BioSpace
Renaissance Technologies LLC Sells 28,100 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio's SWOT analysis: innovative dna tech propels stock potential - Investing.com India
Generation Bio Co. (NASDAQ:GBIO) Sees Large Increase in Short Interest - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World
Rhumbline Advisers Buys 5,430 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Bank of New York Mellon Corp Has $527,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Comparative life cycle assessment for PBAT from fossil-derived and 2nd generation biobased feedstocks - ScienceDirect.com
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech
GrowGeneration Corp [GRWG] Investment Guide: What You Need to Know - Knox Daily
Gen Digital: Strong Growth, Good Fundamentals, And Decent Price Action Make A Buy - Seeking Alpha
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat
Insider Sale Alert: Gen Digital Inc [GEN] – Is it Time to sell? - Knox Daily
Cornercap Investment Counsel Inc. Sells 16,746 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Shares Bought by Acadian Asset Management LLC - Defense World
Choreo LLC Takes $776,000 Position in Genmab A/S (NASDAQ:GMAB) - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Los Angeles Capital Management LLC - Defense World
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - ForexTV.com
Moderna falls on R&D cuts, filing delays, terminated programs - BioWorld Online
Generation Bio (NASDAQ:GBIO) Stock Price Down 0.4% - MarketBeat
Holdings of Generation Bio Co (GBIO) are aligned with the stars - SETE News
Financial Metrics Check: Generation Bio Co (GBIO)’s Ratios for Trailing Twelve Months - The Dwinnex
The Generation Bio Co (GBIO) had a good session last reading, didn’t it? - US Post News
Next Generation Bio-therapeutics Market to Exhibit - openPR
Pipeline Co-Creation - Evotec
Vanguard Group Inc. Buys 18,205 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Q3 2024 Earnings Forecast for Generation Bio Co. (NASDAQ:GBIO) Issued By Wedbush - Defense World
Research Analysts Set Expectations for Generation Bio Co.'s Q3 2024 Earnings (NASDAQ:GBIO) - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance
Generation Bio Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Generation Bio (NASDAQ:GBIO) Stock Rating Reaffirmed by Wedbush - MarketBeat
Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates - MSN
Generation Bio Co (GBIO) Q2 2024 Earnings: Revenue Surges to $4. - GuruFocus.com
Generation Bio Reports Second Quarter 2024 Financial Results - Marketscreener.com
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Generation Bio Co-Aktie (GBIO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Paone Antoinette | CHIEF OPERATING OFFICER |
Jul 01 '24 |
Sale |
2.74 |
6,719 |
18,410 |
13,807 |
Paone Antoinette | CHIEF OPERATING OFFICER |
Jan 02 '24 |
Sale |
1.62 |
2,445 |
3,961 |
5,828 |
Samayoa Phillip | CHIEF STRATEGY OFFICER |
Jan 02 '24 |
Sale |
1.62 |
2,445 |
3,961 |
107,256 |
Appelhans Dannielle | Director |
Dec 08 '23 |
Buy |
1.79 |
7,363 |
13,180 |
7,363 |
Appelhans Dannielle | Director |
Dec 08 '23 |
Buy |
1.82 |
637 |
1,159 |
12,637 |
Appelhans Dannielle | Director |
Dec 04 '23 |
Buy |
1.50 |
12,000 |
18,000 |
12,000 |
Quinn Anthony G. | Director |
Dec 01 '23 |
Buy |
1.41 |
88,495 |
124,778 |
88,495 |
Rowland Charles A Jr | Director |
Dec 01 '23 |
Buy |
1.31 |
192,960 |
252,778 |
384,757 |
Rowland Charles A Jr | Director |
Dec 04 '23 |
Buy |
1.50 |
150,000 |
225,000 |
534,757 |
Nicholson Donald William | Director |
Dec 01 '23 |
Buy |
1.44 |
100,000 |
144,000 |
213,576 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):